UNIGENE LABORATORIES INC (UGNE)

Watch the video to learn about the probability of UNIGENE LABORATORIES INC (UGNE) Chart Signal as of Oct 31, 2014

Hotstocked Precision will calculate the probabilities of UNIGENE LABORATORIES INC (UGNE)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD
Recent Material Events for UNIGENE LABORATORIES INC
Date Description
Dec 21, 2012 Unigene Laboratories, Inc. (the “Company”) today announced that a settlement agreement was entered into between the Company and Ostrolenk Faber LLP (“Ostrolenk”), the Company’s former patent counsel.
Dec 21, 2012 Unigene Laboratories, Inc. (the “Company”) today announced that a settlement agreement was entered into between the Company and Ostrolenk Faber LLP (“Ostrolenk”), the Company’s former patent counsel.
Dec 21, 2012 On December 21, 2012, Unigene Laboratories, Inc., a Delaware corporation (the "Company"), entered into an agreement (the "Revised Settlement Agreement") with the Jaynjean Levy Family Limited Partnership (the “Partnership”), Warren P. Levy
Dec 21, 2012 On December 21, 2012, Unigene Laboratories, Inc., a Delaware corporation (the "Company"), entered into an agreement (the "Revised Settlement Agreement") with the Jaynjean Levy Family Limited Partnership (the “Partnership”), Warren P. Levy
Dec 19, 2012 Unigene Laboratories, Inc. today announced that the Special Meeting of Shareholders in Lieu of the 2012 Annual Shareholder meeting scheduled for January 15, 2013 in Chicago has been postponed until further notice, pending the completion of the financ
Dec 14, 2012 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Dec 12, 2012 On September 8, 2011, the United States Patent and Trademark Office (“USPTO”) granted a request for inter partes reexamination of the Fortical Patent filed by Apotex on July 15, 2011. Unigene filed its response to the Reexamination Office
Dec 12, 2012 On December 12, 2012, Unigene Laboratories, Inc. (the “ Company ”) a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announced that the results of its successful Phase 2 clinical trial evaluating
Dec 12, 2012 On September 8, 2011, the United States Patent and Trademark Office (“USPTO”) granted a request for inter partes reexamination of the Fortical Patent filed by Apotex on July 15, 2011. Unigene filed its response to the Reexamination Office
Dec 11, 2012 On December 11, 2012, Unigene Laboratories, Inc. (the “ Company ”) announced that it has retained Canaccord Genuity to assist the Company with its exploration and evaluation of a broad range of strategic options, including, but not limite

Watch the video to learn about the probability of UNIGENE LABORATORIES INC (UGNE) Chart Signal as of Oct 31, 2014

This free program will calculate the probabilities of UNIGENE LABORATORIES INC (UGNE) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD